Today's Change
+0.85%
AI Sentiment
59%
Sector AnalysisLive data
Materials Sector Outlook
The Materials sector is up 0.85% today with neutral sentiment across 14 recent news articles. Top movers include $CDTTW (+65.33%), $ERNAW (+63.87%), $TMCWW (+60.68%).
Bullish Factors
- No strong bullish signals detected
Risk Factors
- No strong bearish signals detected
Stocks in Materials
198 stocks| Symbol | Company | Change |
|---|---|---|
| $ANABV | AnaptysBio Inc | +0.00% |
| $KTTAW | Pasithea Therapeutics Corp - Warrants (11/08/2026) | -1.23% |
| $TVGNW | Tevogen Bio Holdings Inc - Warrants (14/02/2029) | +12.66% |
| $CINGW | Cingulate Inc - Warrants (03/12/2026) | -10.38% |
| $TMCWW | TMC the metals company Inc - Warrants (09/09/2026) | +60.68% |
| $GRMLW | Greenland Mines Ltd - Warrants(21/06/2029) | +11.00% |
| $DRMAW | Dermata Therapeutics Inc - Warrants (13/08/2026) | -8.87% |
| $ORGNW | Origin Materials Inc - Warrants (23/06/2026) | -18.18% |
| $HUMAW | Humacyte Inc - Warrants (27/08/2026) | +5.13% |
| $SCLXW | Scilex Holding Company - Warrants (10/11/2027) | -6.43% |
| $SBFMW | Sunshine Biopharma Inc - Warrants (15/02/2027) | +0.00% |
| $ASBPW | Aspire Biopharma Holdings Inc - Warrants (18/02/2030) | +7.88% |
| $SRZNW | Surrozen Inc - Warrants (01/08/2026) | +5.00% |
| $NAMSW | NewAmsterdam Pharma Company NV - Warrants (15/11/2027) | +21.31% |
| $NBY | NovaBay Pharmaceuticals, Inc. | +0.00% |
Materials News
805 articles
Benzinga39d ago
BiomX Obtains Option to Acquire Control of Israeli Laser-Radar Counter-Drone System
GlobeNewswire Inc.39d ago
Portnoy Law Firm Announces Class Action on Behalf of uniQure N.V. Investors
GlobeNewswire Inc.39d ago
Portnoy Law Firm Announces Class Action on Behalf of Ultragenyx Pharmaceutical, Inc. Investors
GlobeNewswire Inc.39d ago
Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform
GlobeNewswire Inc.39d ago
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting
GlobeNewswire Inc.39d ago
Biomea Fusion Announces First Patient Dosed in Newly Initiated Phase II Programs Enrolling Type 2 Diabetes Patients Failing on Standard-of-Care Therapies
GlobeNewswire Inc.39d ago
ROSEN, THE FIRST FILING FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX
GlobeNewswire Inc.39d ago
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – CORT
The Motley Fool39d ago
Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD
The Motley Fool39d ago
Sionna Chief Legal Officer Cashed Out Her Shares. Her Options Are Another Story
Market Sentiment
Neutral
59% Sentiment Score
Sector Stats
Total Stocks198
News Today14
Avg Volume1.3M
AI SentimentNeutral